Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Kompaniya haqida

Takeda Pharmaceutical Company Limited farmatsevtika mahsulotlarini tadqiq qilish, ishlab chiqish, ishlab chiqarish, marketing va litsenziyalash bilan shug'ullanadi. Kompaniya gastroenterologiya, kam uchraydigan kasalliklar, plazmadan olingan terapiyalar, onkologiya, vaktsinalar va nevrologiya sohalarida farmatsevtika mahsulotlarini taklif etadi. Kompaniya o'z mahsulotlarini Entyvio, Gattex/Revestive, Takecab/Vocinti, EOHILIA, Takhzyro, Advate, Elaprase, Replagal, Vpriv, Adynovate/Adynovi, Livtencity, ADZYNMA, Gammagard Liquid/Kiovig, Hyqvia, Cuvitru, Flexbumin, Adcetris, Leuplin/Enantone, Ninlaro, Iclusig, FRUZAQLA, Alunbrig, vyvanse/elvanse, Trintellix va QDENGA brendlari ostida sotadi. Kompaniya Arrowhead Pharmaceuticals, Cour Pharmaceuticals, Engitix, Halozyme, Mirum Pharmaceuticals, Ucsd/Fortis Advisors, Zedira/Dr. Falk Pharma, Ac Immune, Acurastem, Anima Biotech, Biomarin, Denali Therapeutics, Luxna Biotech, Neurocrine Biosciences, Peptidream, Abbvie, Adimab, Ascentage Pharma, Crescendo Biologics, Exelixis, F-Star, Gsk, Heidelberg Pharma, Innovent Biologics, Keros Therapeutics, Kumquat Biosciences, Protagonist Therapeutics, Halozyme, Kamada, Johnson & Johnson/Momenta Pharmaceuticals, Previpharma, Novavax, Bridgene Biosciences, Charles River Laboratories, Iambic Therapeutics, Ipsen, Km Biologics, Massachusetts Institute Of Technology va Nabla Bio bilan mahsulotlarni ishlab chiqish va tijoratlashtirish bo'yicha litsenziyalash va hamkorlikni yo'lga qo'ygan. Kompaniya Yaponiya, Qo'shma Shtatlar, Yevropa, Kanada, Lotin Amerikasi, Xitoy, Osiyo, Rossiya/Mustaqil Davlatlar Hamdo'stligi, Yaqin Sharq, Okeaniya va Afrikada faoliyat yuritadi. Kompaniya 1781 yilda tashkil etilgan va uning bosh qarorgohi Chuo, Yaponiyada joylashgan.